C3PR BRIDG Compliance Report

From CTMS_WIKI

Introduction

Background

The Cancer Center Participant Registry (C3PR) is a web-based application used for end-to-end registration of patients to clinical trials. This includes capturing the consent signed date, eligibility criteria, stratification, randomization, and screening. Clinical workflows are enabled by both subject- and study-centric views into the registration process. C3PR can be run in a standalone mode where study definitions, investigators, study personnel, and sites are entered into the system, or C3PR can be run in an integrated mode with the caBIG Clinical Trials Suite (CCTS). C3PR also enables multi-site clinical trials where registration information is entered locally at affiliate sites and the registration is completed by call-out to the coordinating site.

Throughout the development of C3PR, a number of elaborator and adopter sites are actively being engaged to help define requirements and test the application. Our primary elaborators include Duke, Wake Forest, Mayo, Westat, CALGB, CCR, and the Coalition of Cooperative Groups. Our primary adopters include Duke and Wake Forest with engagement of Georgetown and CCR.

C3PR release 1 was developed by Nortel Solutions and released in 2006. Release 2 was developed by Duke Cancer Center in collaboration with SemanticBits, LLC and was released in March, 2008. We are currently in the next phase of development with releases slated for the end of September, 2008 and March, 2009.

Scope

This document describes the mapping between the C3PR implementation model and the BRIDG 2.1 analysis model.

Related Documentation

BRIDG Mapping